KURLAND FRED 4
4 · Aridis Pharmaceuticals, Inc. · Filed Aug 1, 2019
Insider Transaction Report
Form 4
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Stock Options
2019-06-05+15,000→ 54,575 totalExercise: $9.03Exp: 2029-06-05→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]1/48th of the stock options vest in equal installments on the 5th calendar day of each month beginning on July 5, 2019.